Literature DB >> 30223008

The phenotypic and mutational spectrum of Thai female patients with ornithine transcarbamylase deficiency.

Voranush Chongsrisawat1, Ponghatai Damrongphol2, Chupong Ittiwut2, Rungnapa Ittiwut2, Kanya Suphapeetiporn3, Vorasuk Shotelersuk2.   

Abstract

Ornithine transcarbamylase deficiency (OTCD) is an X-linked urea cycle disorder affecting both males and females. Hemizygous males commonly present with severe hyperammonemic encephalopathy during the neonatal period. Heterozygous females have great phenotypic variability. The majority of female patients can manifest later in life or have unrecognized symptoms, making the diagnosis of OTCD in females very challenging. Here we report on three unrelated Thai female cases with OTCD presenting with different manifestations including aggressive behavior, acute liver failure and severe encephalopathy. Whole exome sequencing successfully identified disease-causing mutations in all three cases including two novel ones: the c.209_210delAA (p.Lys70Argfs*17) and the c.850T>A (p.Tyr284Asn). This study affirms variable symptoms in female patients with OTCD and emphasizes the importance of early recognition and prompt management for favorable outcomes. In addition, identification of two novel causative variants expands the genotypic spectrum of OTC.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Female; Hyperammonemia; Novel mutations; OTC; Ornithine transcarbamylase deficiency

Mesh:

Substances:

Year:  2018        PMID: 30223008     DOI: 10.1016/j.gene.2018.09.026

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  Acute liver dysfunction with delayed peak of serum aminotransferase levels as a presentation of ornithine transcarbamylase deficiency in females.

Authors:  Kathryn Clarkston; Joy Lee; Sarah Donoghue; Heidi Peters; Hernan Eiroa; Amit A Shah; Kathleen Loomes; Jessica Wen; Mark Oliver; Winita Hardikar; Carlos E Prada; Akihiro Asai
Journal:  Am J Med Genet A       Date:  2020-12-24       Impact factor: 2.802

2.  The E273del variant of uncertain significance of the ornithine transcarbamylase gene - a case for reclassification.

Authors:  Nicole Ducich; Nicholas Ah Mew; Jirair K Bedoyan
Journal:  Mol Genet Metab Rep       Date:  2020-05-08

3.  Clinical and cranial MRI features of female patients with ornithine transcarbamylase deficiency: Two case reports.

Authors:  Dan Yu; Guoyan Lu; Rajah Mowshica; Yan Cheng; Fumin Zhao
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

4.  Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency.

Authors:  Deyun Lu; Feng Han; Wenjuan Qiu; Huiwen Zhang; Jun Ye; Lili Liang; Yu Wang; Wenjun Ji; Xia Zhan; Xuefan Gu; Lianshu Han
Journal:  Orphanet J Rare Dis       Date:  2020-12-03       Impact factor: 4.123

5.  Clinical and genetic analysis of five Chinese patients with urea cycle disorders.

Authors:  Zhenzhu Zheng; Yiming Lin; Weihua Lin; Lin Zhu; Mengyi Jiang; Wenjun Wang; Qingliu Fu
Journal:  Mol Genet Genomic Med       Date:  2020-05-15       Impact factor: 2.183

6.  CRISPR Start-Loss: A Novel and Practical Alternative for Gene Silencing through Base-Editing-Induced Start Codon Mutations.

Authors:  Siyu Chen; Wanhua Xie; Zhiquan Liu; Huanhuan Shan; Mao Chen; Yuning Song; Hao Yu; Liangxue Lai; Zhanjun Li
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-31       Impact factor: 8.886

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.